Literature DB >> 15168108

Wegener granulomatosis in childhood and adolescence.

Michael Frosch1, Dirk Foell.   

Abstract

Wegener granulomatosis (WG) is a necrotising granulomatous small vessel vasculitis with a clinical predilection for involvement of the upper airways, lungs and kidneys, which occurs at all ages. The aetiology of WG, like other primary systemic vasculitides, remains unknown. Existing evidence suggests an autoimmune inflammatory process, characterised by early lesions with neutrophils and endothelial cells as active participants and involvement of antineutrophil cytoplasmatic antibodies (ANCA) directed against proteinase-3 (PR3). However, other concomitant factors like infections and environmental factors also appear to be necessary for the development of WG. In addition, multiple genetic factors seem to be involved in disease susceptibility. Whereas the first publications on WG in childhood were based on case reports, some studies in recent years allow to compare clinical findings, disease course, morbidity and mortality rates for childhood and adult onset patients. Whereas most aspects of WG are similar at all ages, some features appear to be significantly different. WG in childhood is more frequently complicated by subglottic stenosis and nasal deformity while treatment-related morbidity and malignancies are less common compared to adults. Introduction of combined treatment with cyclophosphamide and glucocorticoids resulted in a dramatic improvement of patient outcome; however, commonly occurring disease relapses and the risk of chronic organ damage at all ages make long-term follow-up of all patients and the establishment of new therapeutic regimens necessary. Copyright 2004 Springer-Verlag

Entities:  

Mesh:

Year:  2004        PMID: 15168108     DOI: 10.1007/s00431-004-1464-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  85 in total

Review 1.  Rare diseases.3: Wegener's granulomatosis.

Authors:  C A Langford; G S Hoffman
Journal:  Thorax       Date:  1999-07       Impact factor: 9.139

Review 2.  New approaches to treatment in systemic vasculitis: biological therapies.

Authors:  S M Levine; J H Stone
Journal:  Best Pract Res Clin Rheumatol       Date:  2001-06       Impact factor: 4.098

Review 3.  Primary systemic vasculitis.

Authors:  C O Savage; L Harper; D Adu
Journal:  Lancet       Date:  1997-02-22       Impact factor: 79.321

Review 4.  Vasculitis in children.

Authors:  B H Athreya
Journal:  Pediatr Clin North Am       Date:  1995-10       Impact factor: 3.278

5.  A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.

Authors:  L Guillevin; J F Cordier; F Lhote; P Cohen; B Jarrousse; I Royer; P Lesavre; C Jacquot; P Bindi; P Bielefeld; J F Desson; F Détrée; A Dubois; E Hachulla; B Hoen; D Jacomy; C Seigneuric; D Lauque; M Stern; M Longy-Boursier
Journal:  Arthritis Rheum       Date:  1997-12

6.  Outcome of antineutrophil cytoplasmic autoantibodies-positive glomerulonephritis and vasculitis in children: a single-center experience.

Authors:  R P Valentini; W E Smoyer; A B Sedman; D B Kershaw; M J Gregory; T E Bunchman
Journal:  J Pediatr       Date:  1998-02       Impact factor: 4.406

7.  Sulfamethoxazole-trimethoprim therapy for Wegener's granulomatosis.

Authors:  H L Israel
Journal:  Arch Intern Med       Date:  1988-10

8.  Clinical features and therapeutic management of subglottic stenosis in patients with Wegener's granulomatosis.

Authors:  C A Langford; M C Sneller; C W Hallahan; G S Hoffman; W A Kammerer; C Talar-Williams; A S Fauci; R S Lebovics
Journal:  Arthritis Rheum       Date:  1996-10

9.  Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis.

Authors:  J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

10.  Limited versus severe Wegener's granulomatosis: baseline data on patients in the Wegener's granulomatosis etanercept trial.

Authors:  John H Stone
Journal:  Arthritis Rheum       Date:  2003-08
View more
  10 in total

1.  [ANCA-negative subglottic laryngeal stenosis in childhood].

Authors:  C Wittekindt; J-C Lüers; U Drebber; O Guntinas-Lichius; K-B Hüttenbrink
Journal:  HNO       Date:  2007-10       Impact factor: 1.284

2.  Atypical Conjunctival Lesion as the Initial Presentation of Granulomatosis With Polyangiitis in an Adolescent Male.

Authors:  Wathanee Sripawadkul; Mike Zein; Anat Galor; Rafael Rivas-Chacon; Rayan Abou Khzam; Sander R Dubovy; Carol L Karp
Journal:  Cornea       Date:  2022-03-30       Impact factor: 3.152

3.  Chest CT findings in pediatric Wegener's granulomatosis.

Authors:  Daniel Levine; Jonathan Akikusa; David Manson; Earl Silverman; Rayfel Schneider
Journal:  Pediatr Radiol       Date:  2006-10-28

4.  Proteinase 3 is an IL-32 binding protein.

Authors:  Daniela Novick; Menachem Rubinstein; Tania Azam; Aharon Rabinkov; Charles A Dinarello; Soo-Hyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-17       Impact factor: 11.205

Review 5.  Vasculitis in children and adolescents: clinical presentation, etiopathogenesis, and treatment.

Authors:  Kjell Tullus; Stephen D Marks
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

6.  Identification of the most active interleukin-32 isoform.

Authors:  Ji-Da Choi; Su-Young Bae; Jae-Woo Hong; Tania Azam; Charles A Dinarello; Erk Her; Whan-Soo Choi; Bo-Kyung Kim; Chang-Kwon Lee; Do-Young Yoon; Sun-Jong Kim; Soo-Hyun Kim
Journal:  Immunology       Date:  2008-09-02       Impact factor: 7.397

7.  Asymptomatic intracardiac mass in a 14-year-old girl with granulomatosis with polyangiitis: Case report.

Authors:  Julia G Harris; David M Salvay; Marisa S Klein-Gitelman
Journal:  Pediatr Rheumatol Online J       Date:  2012-04-13       Impact factor: 3.054

8.  [Atypical presentation of granulomatosis with polyangiitis: about a pediatric observation].

Authors:  Olfa Berriche; Samia Younes; Wafa Ammari; Wafa Alaya; Wassia Kessomtini; Sonia Hammami
Journal:  Pan Afr Med J       Date:  2015-06-22

9.  The Diagnosing Challenge of a Positive ANCA Vasculitis in the Paediatric Age.

Authors:  Clara Preto; Armandina Silva; Sandra Alves; Margarida Guedes; Paula Matos; Conceição Mota; Paula Rocha; Paula C Fernandes
Journal:  Case Rep Pediatr       Date:  2017-12-19

10.  Interleukin-32α promotes the proliferation of multiple myeloma cells by inducing production of IL-6 in bone marrow stromal cells.

Authors:  Xuanru Lin; Li Yang; Gang Wang; Fuming Zi; Haimeng Yan; Xing Guo; Jing Chen; Qingxiao Chen; Xi Huang; Yi Li; Enfan Zhang; Wenjun Wu; Yang Yang; Donghua He; Jingsong He; Zhen Cai
Journal:  Oncotarget       Date:  2017-10-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.